Stocks
Natera, Inc.NTRA
NASDAQHealthcareBiotechnology$187.85-1.29%
Price as of · delayed, not real-time
A diagnostics company specializing in genetic testing and precision medicine, Natera provides non-invasive prenatal testing, cancer screening, and organ health monitoring. Its growth potential stems from expanding adoption of cell-free DNA tests in reproductive health and oncology markets.
Market Cap: $26.6B52W Range: $125.38 – $256.36
Congressional Interest in Natera, Inc. (NTRA)
4 members of Congress have disclosed 8 trades in Natera, Inc. (NTRA), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 4 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
8
Unique Politicians
4
Buys
4
Sells
4
Who in Congress Is Trading NTRA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-22 | Josh Gottheimer | buy | $1K – $15K |
| 2025-08-22 | Josh Gottheimer | buy | $1K – $15K |
| 2025-07-22 | Josh Gottheimer | sell | $1K – $15K |
| 2024-11-20 | Josh Gottheimer | buy | $1K – $15K |
| 2024-08-02 | Rohit Khanna | sell | $1K – $15K |
| 2023-04-10 | Daniel Goldman | sell | $1K – $15K |
| 2023-03-06 | Daniel Goldman | buy | $1K – $15K |
| 2021-04-20 | William F Hagerty, IV | sell | $1K – $15K |